Spectrum of severe ocular complications following dupilumab exposure: A perspective from the ophthalmology clinic
- 19 October 2021
- journal article
- letter
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 87 (2), 469-472
- https://doi.org/10.1016/j.jaad.2021.10.015
Abstract
No abstract availableKeywords
Funding Information
- University of California San Diego
This publication has 5 references indexed in Scilit:
- Dermatology-ophthalmology collaborations are needed in dupilumab-associated ocular eventsJournal of the American Academy of Dermatology, 2021
- Real-world evidence of dupilumab efficacy and risk of adverse events: A systematic review and meta-analysisJournal of the American Academy of Dermatology, 2020
- Long-term effectiveness and safety of treatment with dupilumab in patients with atopic dermatitis: Results of the TREAT NL (TREatment of ATopic eczema, the Netherlands) registryJournal of the American Academy of Dermatology, 2020
- Conjunctivitis in dupilumab clinical trialsBritish Journal of Dermatology, 2019
- Goblet cell scarcity and conjunctival inflammation during treatment with dupilumab in patients with atopic dermatitisBritish Journal of Dermatology, 2018